707 related articles for article (PubMed ID: 33072105)
1. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
Terry LV; Oo YH
Front Immunol; 2020; 11():565518. PubMed ID: 33072105
[TBL] [Abstract][Full Text] [Related]
2. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
Janssens I; Cools N
Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
[TBL] [Abstract][Full Text] [Related]
3. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
4. Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease.
Richardson N; Wootton GE; Bozward AG; Oo YH
Semin Immunopathol; 2022 Jul; 44(4):461-474. PubMed ID: 35641679
[TBL] [Abstract][Full Text] [Related]
5. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
Selck C; Dominguez-Villar M
Front Immunol; 2021; 12():661875. PubMed ID: 34054826
[TBL] [Abstract][Full Text] [Related]
6. CAR Treg: A new approach in the treatment of autoimmune diseases.
Beheshti SA; Shamsasenjan K; Ahmadi M; Abbasi B
Int Immunopharmacol; 2022 Jan; 102():108409. PubMed ID: 34863655
[TBL] [Abstract][Full Text] [Related]
7. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.
Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Amirzargar A
Int Immunopharmacol; 2021 Aug; 97():107669. PubMed ID: 33965760
[TBL] [Abstract][Full Text] [Related]
8. Building a CAR-Treg: Going from the basic to the luxury model.
Rosado-Sánchez I; Levings MK
Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.
Boroughs AC; Larson RC; Choi BD; Bouffard AA; Riley LS; Schiferle E; Kulkarni AS; Cetrulo CL; Ting D; Blazar BR; Demehri S; Maus MV
JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869654
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific regulatory T cells: are police CARs the answer?
Dawson NAJ; Levings MK
Transl Res; 2017 Sep; 187():53-58. PubMed ID: 28688236
[TBL] [Abstract][Full Text] [Related]
11. Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment.
Mashayekhi K; Khazaie K; Faubion WA; Kim GB
Bioact Mater; 2024 Jul; 37():269-298. PubMed ID: 38694761
[TBL] [Abstract][Full Text] [Related]
12. The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology.
Mohseni YR; Tung SL; Dudreuilh C; Lechler RI; Fruhwirth GO; Lombardi G
Front Immunol; 2020; 11():1608. PubMed ID: 32793236
[TBL] [Abstract][Full Text] [Related]
13. Engineered Treg cells: The heir to the throne of immunotherapy.
Stucchi A; Maspes F; Montee-Rodrigues E; Fousteri G
J Autoimmun; 2024 Apr; 144():102986. PubMed ID: 36639301
[TBL] [Abstract][Full Text] [Related]
14. Utilization of Treg Cells in Solid Organ Transplantation.
Juneja T; Kazmi M; Mellace M; Saidi RF
Front Immunol; 2022; 13():746889. PubMed ID: 35185868
[TBL] [Abstract][Full Text] [Related]
15. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
Romano M; Fanelli G; Albany CJ; Giganti G; Lombardi G
Front Immunol; 2019; 10():43. PubMed ID: 30804926
[TBL] [Abstract][Full Text] [Related]
16. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
Koristka S; Kegler A; Bergmann R; Arndt C; Feldmann A; Albert S; Cartellieri M; Ehninger A; Ehninger G; Middeke JM; Bornhäuser M; Schmitz M; Pietzsch J; Akgün K; Ziemssen T; Steinbach J; Bachmann MP
J Autoimmun; 2018 Jun; 90():116-131. PubMed ID: 29503042
[TBL] [Abstract][Full Text] [Related]
17. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
[TBL] [Abstract][Full Text] [Related]
18. Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis.
Oo YH; Ackrill S; Cole R; Jenkins L; Anderson P; Jeffery HC; Jones N; Jeffery LE; Lutz P; Wawman RE; Athwal AK; Thompson J; Gray J; Guo K; Barton D; Hirschfield GM; Wong T; Guest P; Adams DH
JHEP Rep; 2019 Oct; 1(4):286-296. PubMed ID: 32039380
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the inherent power of chimeric antigen receptor (CAR)-expressing regulatory T cells (CAR-Tregs) to treat autoimmune-related disorders.
Kahmini FR; Shahgaldi S
Mol Biol Rep; 2022 May; 49(5):4069-4078. PubMed ID: 35534581
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
